Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma
Top Cited Papers
Open Access
- 1 December 2002
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 2 (6) , 485-495
- https://doi.org/10.1016/s1535-6108(02)00215-5
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancerNature Genetics, 2002
- The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug targetOncogene, 2002
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Paxillin: a focal adhesion-associated adaptor proteinOncogene, 2001
- Paxillin Localizes to the Lymphocyte Microtubule Organizing Center and Associates with the Microtubule CytoskeletonJournal of Biological Chemistry, 2000
- Stat3 as an OncogenePublished by Elsevier ,1999
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- Oesophageal cancer in never‐smokers and never‐drinkersInternational Journal of Cancer, 1995
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- CpG-rich islands and the function of DNA methylationNature, 1986